US Patent 7897605 Pyrimidine compounds
Patent 7897605 was granted and assigned to Cyclacel on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+299 characters)
Article
Patent abstract
The present invention relates to substituted pyrimidines of formula I, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders and/or viral disorders.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Campbell McInnes0
Christopher Meades0
Gavin Wood0
Janice O'Boyle0
Peter Martin Fischer0
Shudong Wang0
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07897605 Pyrimidine compounds US Patent 7897605 Pyrimidine compounds
Infobox
Patent Number
078976050
Patent Number
78976050
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
078976050
Date of Patent
March 1, 2011
0Patent Application Number
122208570
Date Filed
July 29, 2008
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07897605 Pyrimidine compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07897605
Date of patent
March 1, 2011
Patent application number
12220857
Date Filed
July 29, 2008
Patent primary examiner
Find more entities like US Patent 7897605 Pyrimidine compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
